1. Search Result
Search Result
Results for "

NSCs

" in MedChemExpress (MCE) Product Catalog:

415

Inhibitors & Agonists

1

Screening Libraries

6

Fluorescent Dye

2

Biochemical Assay Reagents

10

Peptides

1

Inhibitory Antibodies

68

Natural
Products

50

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-120782

    Notch Neurological Disease
    Yhhu-3792 enhances the self-renewal capability of neural stem cells (NSCs). Yhhu-3792 activates Notch signaling pathway and promotes the expression of Hes3 and Hes5. Yhhu-3792 expands the NSCs pool and promotes endogenous neurogenesis in the hippocampal dentate gyrus (DG) in mouse. Yhhu-3792 increases the spatial and episodic memory abilities of mice. Yhhu-3792 has the potential for the research of impairment of learning and memory associated DG dysfunction .
    Yhhu-3792
  • HY-15036
    Diclofenac
    15+ Cited Publications

    COX Apoptosis Inflammation/Immunology Cancer
    Diclofenac is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells , and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively . Diclofenac induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade .
    Diclofenac
  • HY-15038
    Diclofenac potassium
    15+ Cited Publications

    COX Apoptosis Inflammation/Immunology Cancer
    Diclofenac potassium is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells , and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively . Diclofenac potassium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade .
    Diclofenac potassium
  • HY-15036A
    Diclofenac diethylamine
    15+ Cited Publications

    COX Apoptosis Inflammation/Immunology Cancer
    Diclofenac diethylamine is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells , and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively . Diclofenac diethylamine induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade .
    Diclofenac diethylamine
  • HY-15037
    Diclofenac Sodium
    15+ Cited Publications

    GP 45840

    COX Apoptosis Inflammation/Immunology Cancer
    Diclofenac Sodium (GP 45840) is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells , and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively . Diclofenac Sodium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade .
    Diclofenac Sodium
  • HY-101796

    Ras SOS1 Cancer
    NSC-70220 is a selective and allosteric SOS1 inhibitor. NSC-70220 inhibits allosteric site activation, and partially inhibited catalytic site activation. NSC-70220 has an anticancer effect .
    NSC-70220
  • HY-153719

    SARS-CoV Infection
    NSC111552 is a potent SARS-CoV-2 NSP14 MTase inhibitor. NSC111552 inhibits the FL-NAH binding to the SARS-CoV-2 NSP14 MTase with an IC50 of 5.1 μM .
    NSC111552
  • HY-120782A

    Notch Neurological Disease
    Yhhu-3792 hydrochloride enhances the self-renewal capability of neural stem cells (NSCs). Yhhu-3792 hydrochloride activates Notch signaling pathway and promotes the expression of Hes3 and Hes5. Yhhu-3792 hydrochloride expands the NSCs pool and promotes endogenous neurogenesis in the hippocampal dentate gyrus (DG) in mouse. Yhhu-3792 hydrochloride increases the spatial and episodic memory abilities of mice. Yhhu-3792 hydrochloride has the potential for the research of impairment of learning and memory associated DG dysfunction .
    Yhhu-3792 hydrochloride
  • HY-15038R

    COX Apoptosis Inflammation/Immunology Cancer
    Diclofenac (potassium) (Standard) is the analytical standard of Diclofenac (potassium). This product is intended for research and analytical applications. Diclofenac potassium is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells , and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively . Diclofenac potassium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade .
    Diclofenac (potassium) (Standard)
  • HY-15036R

    COX Apoptosis Inflammation/Immunology Cancer
    Diclofenac (Standard) is the analytical standard of Diclofenac. This product is intended for research and analytical applications. Diclofenac is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells , and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively . Diclofenac induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade .
    Diclofenac (Standard)
  • HY-15036AR

    COX Apoptosis Inflammation/Immunology Cancer
    Diclofenac (diethylamine) (Standard) is the analytical standard of Diclofenac (diethylamine). This product is intended for research and analytical applications. Diclofenac diethylamine is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells , and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively . Diclofenac diethylamine induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade .
    Diclofenac (diethylamine) (Standard)
  • HY-160638

    TET Protein Cancer
    NSC-311068 is TET1 inhibitor. NSC-311068 selectively suppress TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification. NSC-311068 represses the level of TET1 expression and the global 5hmC level. NSC-311068 effectively inhibits cell viability in AML cells with high expression of TET1 .
    NSC-311068
  • HY-117481

    Apoptosis Cancer
    NSC-639829 is a Benzoylphenylurea (BPU) analogue which has antitumor activity. NSC-639829 is promising for research of refractory metastatic cancer .
    NSC-639829
  • HY-164402

    DNA/RNA Synthesis Cancer
    NSC-124854 is a DNA polymerase β (Pol-β) inhibitor with an IC50 of 5.3 μM. NSC-124854 has antitumor activity .
    NSC-124854
  • HY-117831

    Bacterial Antibiotic Endogenous Metabolite Infection
    NSC-79887 is a nucleoside hydrolase (NH) inhibitor with activity against Bacillus anthracis. NSC-79887 is considered a good candidate inhibitor of nucleoside hydrolases for biological testing and further development. The pharmacokinetic (ADMET) prediction of NSC-79887 showed that all physicochemical parameters were within the acceptable range for human use .
    NSC-79887
  • HY-114557R

    Endogenous Metabolite Metabolic Disease
    NSC 90469 (Standard) is the analytical standard of NSC 90469. This product is intended for research and analytical applications. NSC 90469 is an endogenous metabolite.
    NSC 90469 (Standard)
  • HY-B1476R

    Endogenous Metabolite Metabolic Disease
    NSC 42196 (Standard) is the analytical standard of NSC 42196. This product is intended for research and analytical applications. NSC 42196 is an endogenous metabolite.
    NSC 42196 (Standard)
  • HY-19539

    SOS1 Ras Cancer
    NSC-658497 is an effective inhibitor of Ras-GEF, SOS1. NSC-658497 binds to SOS1, competitively suppresses SOS1-Ras interaction, and dose-dependently inhibits SOS1 GEF activity. NSC-658497 showed dose-dependent efficacy in inhibiting Ras, downstream signaling activities, and associated cell proliferation .
    NSC-658497
  • HY-15432

    (E/Z)-b-AP15

    Deubiquitinase Cancer
    (E/Z)-NSC-687852 is a isomer of NSC-687852 (HY-13989). NSC687852 (b-AP15) is a specific inhibitor of the deubiquitinating enzymes UCHL5 and Usp14 .
    (E/Z)-NSC-687852
  • HY-123395

    Endogenous Metabolite Neurological Disease
    NSC-84096 is an endopeptidase activity inhibitor with the ability to inhibit the activity of botulinum neurotoxin type A light chain (rBoNT/A-LC). NSC-84096 is able to effectively inhibit the enzymatic activity of botulinum neurotoxin in vitro, indicating its potential in inhibiting botulism. The mechanism of action of NSC-84096 may provide hope for the development of small molecule compounds targeting these deadly toxins .
    NSC-84096
  • HY-134309

    Virus Protease Infection
    NSC 288387 is a pan-flavivirus MTase inhibitor. NSC 288387 binds to the SAM-binding pocket. NSC 288387 inhibits ZIKV with an IC50 of 0.2 μM. NSC 288387 also inhibits viral replication in cell culture .
    NSC 288387
  • HY-19387
    Didox
    10+ Cited Publications

    NSC-324360

    DNA/RNA Synthesis Cancer
    Didox (NSC-324360) is a synthetic ribonucleotide reductase (RR) inhibitor.
    Didox
  • HY-Y0124S

    α,α-Dimethylglycine-d6; α-Aminoisobutanoic acid-d6

    Isotope-Labeled Compounds Endogenous Metabolite Others
    NSC 16590-d6 is the deuterium labeled NSC 16590. NSC 16590 inhibits the production of endogenous ethylene in the cotyledonary segments of cocklebur.
    NSC 16590-d6
  • HY-122069

    NSC 1

    Bacterial Infection Neurological Disease Cancer
    NSC177365 (NSC 1) is a CcrM inhibitor. NSC177365 is a competitive DNA inhibitor and disrupts DNA binding. NSC177365 has antibacterial activity, with IC50s of 2.3 and 14.6 μM for C. crescentus and M. lincolnii respectively. NSC177365 reverses several neurodegenerative disorders and serve as an anticancer agent .
    NSC177365
  • HY-122258

    STAT TET Protein Cancer
    NSC-370284 is a selective inhibitor of ten-eleven translocation 1 (TET1) and 5-hydroxymethylcytosine (5hmC). NSC-370284 significantly inhibits the level of TET1 expression via targets STAT3/5 .
    NSC-370284
  • HY-Y0124R

    Endogenous Metabolite Others
    NSC 16590 (Standard) is the analytical standard of NSC 16590. This product is intended for research and analytical applications. NSC 16590 inhibits the production of endogenous ethylene in the cotyledonary segments of cocklebur.
    NSC 16590 (Standard)
  • HY-18594

    Drug Derivative Others
    NSC-41589 is N-[2-(methylsulfanyl) phenyl]acetamide.
    NSC-41589
  • HY-152168

    PERK Phosphatase Cancer
    NSC 295642 is a phosphatase inhibitor. NSC 295642 can significantly increase phospho-Erk cytonuclear differences in intact cells. NSC 295642 can be used for the research of cancer .
    NSC 295642
  • HY-16933
    L-Alanosine
    1 Publications Verification

    NSC-153353; SDX-102

    Antibiotic DNA/RNA Synthesis Infection Cancer
    L-Alanosine (NSC-153353), an antibiotic from Streptomyces alanosinicus, has antineoplastic activity. L-Alanosine (NSC-153353) inhibits adenylosuccinate synthetase, which converts inosine monophospate (IMP) into adenylosuccinate. L-Alanosine is the inhibitor for methylthioadenosine phosphorylase (MTAP) .
    L-Alanosine
  • HY-Y0219S1

    s-Triazole-d3; Pyrrodiazole-d3

    Isotope-Labeled Compounds Others
    NSC 83128-d3 is the deuterium labeled NSC 83128 .
    1,2,4-Triazole-d3
  • HY-Y0226S1

    Isotope-Labeled Compounds Others
    NSC 1940-d8 is the deuterium labeled NSC 1940 .
    NSC 1940-d8
  • HY-Y1675S

    m-Acetylanisole-d4; m-Methoxyacetophenone-d4

    Isotope-Labeled Compounds Others
    NSC 65593-d4 is the deuterium labeled NSC 65593 .
    NSC 65593-d4
  • HY-Y0226S2

    Isotope-Labeled Compounds Others
    NSC 1940-d4 is the deuterium labeled NSC 1940 .
    NSC 1940-d4
  • HY-Y0093S

    α,ω-Nonanediol-d14; 1,9-Dihydroxynonane-d14; Nonamethylene Glycol-d14

    Isotope-Labeled Compounds Others
    NSC 5416-d14 is the deuterium labeled NSC 5416 .
    NSC 5416-d14
  • HY-Y0085S

    3,4-Difluorobenzoic acid-d3

    Isotope-Labeled Compounds Others
    NSC 190686-d3 is the deuterium labeled NSC 190686 .
    NSC 190686-d3
  • HY-Y0251S

    m-Nitrophthalic acid-d3; o-Nitrophthalic acid-d3

    Isotope-Labeled Compounds Others
    NSC 3120-d3 is the deuterium labeled NSC 3120 .
    3-Nitrophthalic acid-d3
  • HY-52155S

    Isotope-Labeled Compounds Others
    NSC 89275-d12 is the deuterium labeled NSC 89275 .
    NSC 89275-d12
  • HY-Y1630S

    Para-fluoronitrobenzene-d4; p-Fluoronitrobenzene-d4; p-Nitrofluorobenzene-d4

    Isotope-Labeled Compounds Others
    NSC 10281-d4 is the deuterium labeled NSC 10281 .
    NSC 10281-d4
  • HY-145330

    DNA/RNA Synthesis Cancer
    NSC639828 is a potent inhibitor of DNA polymerase α with an IC50 of 70 μM. NSC639828 has high antitumor activity. NSC639828 has the potential for researching cancer disease .
    NSC639828
  • HY-122101

    JAK Apoptosis Cancer
    NSC114792 is a selective JAK3 inhibitor. NSC114792 induces apoptosis. NSC114792 decreases the protein expression of p-JAK3 and p-STAT5 .
    NSC114792
  • HY-114658

    NSC-109351

    Biochemical Assay Reagents Cancer
    Daunomycinone (NSC-109351) is a metabolite of daunomycin. Daunomycin is an antibiotic with antitumor activity .
    Daunomycinone
  • HY-168602

    E1/E2/E3 Enzyme Cancer
    NSC-217913 is an inhibitor of WWP1 with an IC50 value of 158.3 μM .
    NSC-217913
  • HY-144444

    EGFR Cancer
    NSC381467 is a potent and orally active inhibitor of EGFR tyrosine kinase (EGFR-TK). NSC381467 has strong antiproliferative activities. NSC381467 has the potential for the research of cancer diseases .
    NSC381467
  • HY-144445

    EGFR Cancer
    NSC114126 is a potent and orally active inhibitor of EGFR tyrosine kinase (EGFR-TK). NSC114126 has strong antiproliferative activities. NSC114126 has the potential for the research of cancer diseases .
    NSC114126
  • HY-15827
    NSC 405020
    2 Publications Verification

    MMP Cardiovascular Disease Cancer
    NSC 405020 is a specific MMP14 inhibitor. NSC 405020 can directly interact with the hemopexin domain of MMP14. NSC 405020 reduces the expression of full length and active cleaved Notch3 (NICD3). NSC 405020 can be used to research vestibular schwannoma, hemostasis and thrombosis .
    NSC 405020
  • HY-129666

    Influenza Virus Neurological Disease
    NSC-65847 is a groundbreaking dual inhibitor targeting both viral neuraminidase and Streptococcus pneumoniae neuraminidase.
    NSC-65847
  • HY-141687

    CDK Apoptosis Cancer
    NSC 107512 is a potent inhibitor of cyclin-dependent kinase 9 (CDK9). NSC 107512 is a class of sangivamycin-like molecules (SLM). NSC 107512 inhibits growth and induces apoptosis of multiple myeloma tumors .
    NSC 107512
  • HY-12929

    SU093

    Pim Cancer
    NSC756093 is a potent inhibitor of the GBP1:PIM1 interaction. NSC756093 can potentially revert resistance to paclitaxel. NSC756093 can be used for ovarian cancer research .
    NSC756093
  • HY-164497

    DNA/RNA Synthesis Histone Methyltransferase Cancer
    NSC 641396 is a ribonucleotide reductase (RNR) inhibitor with an IC50 value of 1.2 μM. NSC 641396 is also a protein arginine N-methyltransferase 9 (PRMT9) inhibitor. NSC 641396 has antitumor activity .
    NSC 641396
  • HY-122066

    Others Infection
    NSC47924 is a laminin receptor (LR) inhibitor. NSC47924 affects 37/67 kDa LR cell surface localization and interaction with the cellular prion protein. NSC47924 can be used for testing prion diseases .
    NSC47924

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: